Omada Health Past Earnings Performance
Past criteria checks 2/6
Omada Health has been growing earnings at an average annual rate of 66.1%, while the Healthcare industry saw earnings growing at 11.9% annually. Revenues have been growing at an average rate of 47.6% per year. Omada Health's return on equity is 1.7%, and it has net margins of 1.4%.
Key information
66.06%
Earnings growth rate
90.03%
EPS growth rate
| Healthcare Industry Growth | 8.50% |
| Revenue growth rate | 47.63% |
| Return on equity | 1.70% |
| Net Margin | 1.39% |
| Last Earnings Update | 30 Jun 2026 |
Recent past performance updates
Recent updates
Omada Health: Q2 Shows More Evidence Of Growth Converting Into Earnings
Summary Omada Health (OMDA) delivered strong Q2 results, with 43% revenue growth, margin expansion, and positive adj. EBITDA, reinforcing my buy rating. OMDA’s product expansion, especially in diabetes and hypertension, is driving higher revenue per member and improving customer-lifetime-value through multi-program adoption. Channel partnerships with PBMs and health plans are lowering CAC, supporting scalable growth and better unit economics, while AI initiatives further enhance operational leverage. Valuation remains attractive; even conservative multiples suggest significant upside if OMDA sustains >40% revenue growth, though partner concentration and investment needs are key risks. Read the full article on Seeking Alpha
OMDA: CEO Transition And Lower Growth Assumptions Will Pressure Future Returns
Analysts now place Omada Health's fair value at $16.56 per share, compared with the prior $15.00. The revised estimate reflects updated assumptions around discount rate, revenue growth, profit margin and future P/E levels.
OMDA: Index Reclassification And Eli Lilly Partnership Will Drive Future Upside
Analysts now place Omada Health's fair value at $24.58 per share, compared with the prior $28.90. They cite updated views on revenue growth, profit margins, the discount rate, and future P/E assumptions.
OMDA: GLP-1 Care Partnership Will Drive Future Earnings Re-Rating
Analysts have trimmed their fair value estimate for Omada Health from $33.00 to $30.00, pointing to updated assumptions around revenue growth, discount rate, profit margin, and future P/E as the main drivers of the shift. What’s in the News for Omada Health Omada Health is set to introduce Omada Identity Sovereign, a containerized identity governance solution aimed at organizations with strict digital sovereignty requirements in Europe, with availability targeted for early 2027.OMDA: GLP-1 Program Reliance Will Drive Lower Future Return Expectations
Analysts have adjusted their Omada Health fair value estimate down from $17.53 to $15.00, as they now apply a slightly higher discount rate and expect lower revenue growth. This is partly offset by assumptions for a higher profit margin and a lower future P/E multiple.Is Omada Health, Inc. (NASDAQ:OMDA) Trading At A 34% Discount?
Key Insights Omada Health's estimated fair value is US$23.60 based on 2 Stage Free Cash Flow to Equity Omada Health's...With A 26% Price Drop For Omada Health, Inc. (NASDAQ:OMDA) You'll Still Get What You Pay For
Omada Health, Inc. ( NASDAQ:OMDA ) shareholders that were waiting for something to happen have been dealt a blow with a...Revenue & Expenses Breakdown
How Omada Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 26 | 310 | 4 | 163 | 49 |
| 31 Mar 26 | 283 | -6 | 152 | 45 |
| 31 Dec 25 | 260 | -13 | 142 | 41 |
| 30 Sep 25 | 232 | -26 | 133 | 38 |
| 30 Jun 25 | 210 | -32 | 124 | 37 |
| 31 Mar 25 | 190 | -38 | 116 | 36 |
| 31 Dec 24 | 170 | -47 | 111 | 36 |
| 31 Dec 23 | 123 | -68 | 102 | 34 |
| 31 Dec 22 | 89 | -73 | 89 | 26 |
Quality Earnings: OMDA has a large one-off loss of $2.1M impacting its last 12 months of financial results to 30th June, 2026.
Growing Profit Margin: OMDA became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: OMDA has become profitable over the past 5 years, growing earnings by 66.1% per year.
Accelerating Growth: OMDA has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: OMDA has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (20.5%).
Return on Equity
High ROE: OMDA's Return on Equity (1.7%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/08/16 02:33 |
| End of Day Share Price | 2026/08/14 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Omada Health, Inc. is covered by 14 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vikram Kesavabhotla | Baird |
| Saket Kalia | Barclays |
| Sean Dodge | BMO Capital Markets Equity Research |